Preventing Type 2 Diabetes Mellitus: Room for Residual Risk Reduction After Lifestyle Changes?

E-ISSN： 1873-4286|16|34|3839-3847

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.34, 2010-11, pp. : 3839-3847

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preventing Type 2 Diabetes in High Risk Patients: An Overview of Lifestyle and Pharmacological Measures

Current Drug Targets, Vol. 7, Iss. 2, 2006-01 ,pp. : 211-228

Bentham Science Publishers

Access to resources Recommend Favorite

Preventing Macrovascular Disease in Patients with Type 2 Diabetes Mellitus

By Johansen O.E.

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 4, 2003-01 ,pp. : 283-297

Adis International

Access to resources Recommend Favorite

Preventing type 1 diabetes mellitus: hype and hope

By Leslie R David G

Clinical Medicine, Vol. 4, Iss. 5, 2004-09 ,pp. : 441-445

Royal College Of Physicians

Access to resources Recommend Favorite

Bodyweight Changes Associated with Antihyperglycaemic Agents in Type 2 Diabetes Mellitus

By Hermansen Kjeld Mortensen Lene S.

Drug Safety, Vol. 30, Iss. 12, 2007-01 ,pp. : 1127-1142

Adis International

Access to resources Recommend Favorite

A Risk-Benefit Assessment of Metformin in Type 2 Diabetes Mellitus

By Howlett H.C.S.

Drug Safety, Vol. 20, Iss. 6, 1999-06 ,pp. : 489-503

Adis International

Access to resources Recommend Favorite